French contract drug developer Novasep is investing in its U.S. operation, planning to build a new lab in Pennsylvania that will bolster its manufacturing business.
The Michael J. Fox Foundation awarded a grant to Evotec to support the company's work in Parkinson's disease, bankrolling a project meant to clear the way for new therapies.
Catalent Pharma Solutions is building up its clinical supply capabilities in Asia, expanding a Singapore facility as it works on a sizable expansion in Japan.
Onyx Scientific is set to increase the size of its U.K.-based site by more than 30% as it enjoys the spoils of a lucrative 2015.
Princeton, NJ-based BioClinica is looking to take big steps into the growing realm of helping biopharma with data and costs after launch as it unveils a new division focused on postapproval studies.
PRA Health Sciences recruited a healthcare marketing firm with the goal of refining its pitch to potential trial participants and improving recruitment.
CRO giant Icon has expanded its technology portfolio with a system it says can improve patient randomization and clinical supply in adaptive trials.
Parexel lowered its fiscal-year revenue projections by about 2% despite posting modest growth in the last quarter, working through a sizable restructuring program designed to boost profits.
CRO giant Parexel has inked a new pact with the Optum Life Sciences unit of the nation's largest insurer, UnitedHealth Group, to help lower costs in postapproval studies.
BioClinica's appetite for pacts shows no sign of abating as it announces a new tie-up with Japanese CRO EPS to focus on risk-based monitoring in clinical trials.
Spotlight On... India hopes for a clinical trial upswing; Pierre Fabre taps BioAscent for compound management; and much more...
Biotrial, the CRO that ran a Phase I study that proved deadly, said it's working with authorities to piece together what went wrong while trying to move its business forward.
South Korea's Celltrion has recruited Medidata to provide eClinical technology as it works to develop copycat versions of the world's top-selling biological treatments.
Catalent Pharma Solutions is upgrading a Japanese plant to offer clinical supply services, extending its global network of depots.
CRO Parexel International is buying a 120-employee consulting firm headquartered in Boston, focusing on market access and commercialization.
Acquisitive CRO BioClinica bought a firm that specializes in handling the financial side of clinical trials, picking up technology that automates how sponsors and contractors pay for studies.
Spotlight On... inVentiv opens new Phase I clinic; Pfizer taps Adaptive for immunotherapy R&D; and much more...
Risk-sharing researcher Evotec said it's advancing an early-stage Alzheimer's disease project alongside partner Johnson & Johnson, working to find new approaches to treating the neurodegenerative disorder.
Luxembourg testing outfit Eurofins is deepening its work in biopharma, acquiring a specialist in drug testing headquartered in the Netherlands.
Contract drug developer AMRI bolstered its client roster with three new agreements making use of its R&D, manufacturing and marketing divisions.